AliveDx
About AliveDx
In the world of diagnostics, AliveDx moves quickly and with purpose. Originally a Swiss medtech company, it develops innovative in-vitro diagnostic solutions for allergies, autoimmune diseases, and immunohematology. Around five hundred employees work from locations in Switzerland and Scotland on technologies that help doctors, laboratories, and patients worldwide move forward. In recent years, the company has transformed from publicly listed to privately held, supported by five long-term investors.
Product Portfolio
AliveDx’s product offering consists of three brands that together cover a broad diagnostic spectrum. MosaiQ is a fully automated microarray platform that enables complex tests to be performed simultaneously – quickly, efficiently, and reliably. LumiQ provides an integrated immunofluorescence solution that streamlines workflows and supports consistent results. For manual blood typing and specialist advice, there is the Alba line.
Company Culture
Quick decision-making, taking initiative, and building something that matters – that’s what defines the culture at AliveDx. Employees are given plenty of room to share ideas, take ownership, and make an impact together. A shared mission unites them: contributing to better healthcare through smart, scalable diagnostics. This makes the work not only intellectually engaging but also meaningful. AliveDx’s headquarters is located in Switzerland.
Netherlands
Germany
Spain